MAP Microba Life Sciences

ASX · AU · Healthcare · Health Care Providers · microba.com

—Mkt Cap: —P/E: —1d ago

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It oper…

Industry Peers

Health Care Providers

Key Statistics

Company

Market Cap—

Enterprise Value17.19M USD

Revenue (TTM)10.20M USD

Gross Profit5.14M USD

Net Income (TTM)-10.32M USD

Revenue/Share0.03 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees—

CountryAU

SectorHealthcare

IndustryHealth Care Providers

ISINAU0000209868

Valuation

P/E (Trailing)—

P/E (Forward)-18.57

PEG—

EV/EBITDA-1.33

EV/Revenue1.69

P/S2.09

P/B1.26

EPS (TTM)-0.03

EPS (Forward)-0.00

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin47.49%

Oper. Margin-126.38%

EBITDA Margin-126.40%

Profit Margin-95.34%

ROE-45.98%

ROA-31.49%

Growth

Revenue Growth-1.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.55M USD

CapEx (TTM)2.00M USD

FCF Margin-74.17%

FCF Yield—

Net Debt-2.65M USD

Net Debt/EBITDA0.21

Balance Sheet

Debt/Equity0.10

Current Ratio1.24

Quick Ratio1.00

Book Value/Sh0.04 AUD

Cash/Share0.01 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)0.1182 AUD

Target Range0.1182 AUD – 0.1182 AUD

# Analysts1

Ownership

Shares Out.700.31M

Float291.00M

Insiders38.34%

Institutions24.98%

Technical

SMA 500.0519 AUD

SMA 2000.0647 AUD

Beta2.10

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)120.93K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—